Genelux Common Stock Buy Hold or Sell Recommendation

GNLX Stock   4.13  0.27  6.99%   
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Genelux Common is 'Strong Buy'. Macroaxis provides Genelux Common buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GNLX positions. The advice algorithm takes into account all of Genelux Common's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Genelux Common's buy or sell advice are summarized below:
Real Value
11.47
Target Price
34.33
Hype Value
3.95
Market Value
4.13
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Genelux Common given historical horizon and risk tolerance towards Genelux Common. When Macroaxis issues a 'buy' or 'sell' recommendation for Genelux Common, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Genelux Common Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.
In addition, we conduct extensive research on individual companies such as Genelux and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Genelux Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Genelux Common Buy or Sell Advice

The Genelux recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genelux Common. Macroaxis does not own or have any residual interests in Genelux Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genelux Common's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Genelux CommonBuy Genelux Common
Strong Buy

Market Performance

Very WeakDetails

Volatility

Slightly riskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Genelux Common has a Risk Adjusted Performance of (0.17), Jensen Alpha of (1.78), Total Risk Alpha of (2.17) and Treynor Ratio of (0.65)
We provide advice to complement the regular expert consensus on Genelux Common. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Genelux Common is not overpriced, please check out all Genelux Common fundamentals, including its ebitda, as well as the relationship between the earnings per share and working capital . Given that Genelux Common has a number of shares shorted of 1.88 M, we strongly advise you to confirm Genelux Common market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Genelux Common Trading Alerts and Improvement Suggestions

Genelux Common generated a negative expected return over the last 90 days
Genelux Common has high historical volatility and very poor performance
The company reported the previous year's revenue of 170 K. Net Loss for the year was (28.3 M) with profit before overhead, payroll, taxes, and interest of 11.07 M.
Genelux Common generates negative cash flow from operations
Genelux Common has a frail financial position based on the latest SEC disclosures
About 22.0% of the company shares are held by company insiders
Latest headline from investing.com: Genelux Corp insider sells shares worth over 250k

Genelux Common Returns Distribution Density

The distribution of Genelux Common's historical returns is an attempt to chart the uncertainty of Genelux Common's future price movements. The chart of the probability distribution of Genelux Common daily returns describes the distribution of returns around its average expected value. We use Genelux Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genelux Common returns is essential to provide solid investment advice for Genelux Common.
Mean Return
-1.62
Value At Risk
-7.77
Potential Upside
6.81
Standard Deviation
5.64
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genelux Common historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Genelux Common Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genelux Common or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genelux Common's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genelux stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-1.78
β
Beta against NYSE Composite2.52
σ
Overall volatility
5.68
Ir
Information ratio -0.3

Genelux Common Volatility Alert

Genelux Common exhibits very low volatility with skewness of 0.8 and kurtosis of 4.2. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genelux Common's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genelux Common's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Genelux Common Fundamentals Vs Peers

Comparing Genelux Common's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genelux Common's direct or indirect competition across all of the common fundamentals between Genelux Common and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genelux Common or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genelux Common's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genelux Common by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Genelux Common to competition
FundamentalsGenelux CommonPeer Average
Return On Asset-0.9-0.14
Operating Margin(142.15) %(5.51) %
Current Valuation74.88 M16.62 B
Shares Outstanding26.87 M571.82 M
Shares Owned By Insiders22.30 %10.09 %
Shares Owned By Institutions21.83 %39.21 %
Number Of Shares Shorted1.88 M4.71 M
Price To Book5.68 X9.51 X
Price To Sales651.09 X11.42 X
Revenue170 K9.43 B
Gross Profit11.07 M27.38 B
EBITDA(23.15 M)3.9 B
Net Income(28.3 M)570.98 M
Total Debt2.52 M5.32 B
Book Value Per Share0.74 X1.93 K
Cash Flow From Operations(20.27 M)971.22 M
Short Ratio20.09 X4.00 X
Earnings Per Share(1.16) X3.12 X
Target Price26.0
Number Of Employees2318.84 K
Market Capitalization97.12 M19.03 B
Total Asset27.89 M29.47 B
Retained Earnings(221.52 M)9.33 B
Working Capital17.65 M1.48 B
Net Asset27.89 M
Note: Disposition of 22737 shares by Szalay Aladar of Genelux Common at 3.7131 subject to Rule 16b-3 [view details]

Genelux Common Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genelux . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Genelux Common Buy or Sell Advice

When is the right time to buy or sell Genelux Common? Buying financial instruments such as Genelux Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total25.3M26.4M2.5M2.4M
Total Assets8.1M5.5M27.9M29.3M

Use Investing Ideas to Build Portfolios

In addition to having Genelux Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Currency Funds Thematic Idea Now

Currency Funds
Currency Funds Theme
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Genelux Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genelux Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genelux Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genelux Common Stock:
Check out Genelux Common Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Genelux Stock analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Genelux Common's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genelux Common. If investors know Genelux will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genelux Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.16)
Revenue Per Share
0.007
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.90)
The market value of Genelux Common is measured differently than its book value, which is the value of Genelux that is recorded on the company's balance sheet. Investors also form their own opinion of Genelux Common's value that differs from its market value or its book value, called intrinsic value, which is Genelux Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genelux Common's market value can be influenced by many factors that don't directly affect Genelux Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genelux Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genelux Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genelux Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.